Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The undecaprenyl pyrophosphate-associated peptidoglycan biosynthesis enzyme complex is a vital multi-step pathway in bacteria responsible for the assembly and transport of cell wall building blocks across the cytoplasmic membrane (Bouhss et al., 2008). This complex utilizes the C55-isoprenyl lipid carrier, undecaprenyl phosphate (also known as bactoprenol), to shuttle sugar-peptide building blocks from the cytoplasm to the cell wall assembly site. Key enzymes within this functional complex include MraY and MurG, which synthesize the lipid-linked intermediates Lipid I and Lipid II, and undecaprenyl pyrophosphate phosphatase (UppP/BacA), which recycles the lipid carrier by dephosphorylating undecaprenyl pyrophosphate (Manat et al., 2014). Because this pathway is essential for bacterial survival and lacks a human homolog, it is a major target for various antibiotics. For instance, bacitracin exerts its bactericidal effect by binding to the undecaprenyl pyrophosphate substrate, thereby preventing its recycling and halting cell wall synthesis (Stone & Strominger, 1971; StatPearls, 2023). Other potent agents like vancomycin and teixobactin target the lipid-linked products of this complex, such as Lipid II, to inhibit the final stages of peptidoglycan polymerization and cause cell lysis (Ling et al., 2015).
Inhibition of undecaprenyl pyrophosphate dephosphorylation, sequestration of Lipid II precursors, and inhibition of peptidoglycan polymerization/cross-linking
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Undecaprenyl pyrophosphate-associated peptidoglycan biosynthesis enzyme complex.